Founding Director: Robert Hunt, PhD

Our Vision: Overcoming Epilepsy
There are 65 million people worldwide who live with epilepsy, making it the fourth most common brain disorder and the most common in children.
The UC Irvine Epilepsy Research Center (EpiCenter) is leading the way toward a cure for epilepsy and related brain conditions including autism, intellectual disability and traumatic brain injury. From transformative neuroscience to state-of-the-art medicine, some of the most impactful discoveries in epilepsy research have been made at UC Irvine. Powered by a modular discovery platform that is both flexible and efficient, our world-class team of scientists, physicians and research staff are developing new breakthrough therapies and care strategies for epilepsy. Now, with your support, we will work across boundaries to accelerate our pace in bringing these scientific discoveries into the clinic.
The EpiCenter has been selected as one of 12 high-impact research programs that will be located in the Falling Leaves Foundation Medical Innovation Building.
In This New Facility
Our Competitive Advantage
Empowered by the distinctive One Health approach of UC Irvine Health Affairs that transcends disciplinary boundaries, the EpiCenter comprises faculty and staff from the Susan & Henry College of Health Sciences (which includes the schools of medicine, nursing, pharmacy & pharmaceutical sciences, population & public health) and UCI Health, our regional healthcare delivery system which includes the trailblazing Susan Samueli Integrative Health Institute. With some of the brightest minds in science and medicine working together on a shared mission of advancing new cures, our team is laser-focused on uncovering the basic biology of epilepsy and using this information to create new therapies, with a distinct focus on healing the whole person.
What sets the EpiCenter apart is the rich culture of collaboration and communication between laboratory scientists and clinical investigators. Our modular approach to disease modeling and discovery leverages expertise from all areas of neuroscience and is designed to strategically assemble teams of experts who work side-by-side to study the root causes of epilepsy and develop new treatments and cures — far exceeding the capacity of any single lab. As a result, we have a growing discovery pipeline of breakthrough therapies that includes new lead compounds, gene and cell therapies and natural remedies with promising antiseizure potential in rigorous pre-clinical epilepsy studies.
In addition to high-impact research, the EpiCenter supports the only NIH-funded T32 training program in epilepsy research. Program alumni have assumed leadership positions in academia and the private sector across the United States and now mentor their own trainees, expanding exponentially the impact of our program on the future of the epilepsy research workforce.
As we look to the future, we are setting our sights on an ambitious new vision to become the first epilepsy research center in the world that successfully bridges cutting-edge neuroscience research with state-of-the-art medicine. Our goal is to move beyond transformative basic science discoveries in the laboratory and bring them into the clinic, so we can help as many people as possible.
Robert Hunt, PhD
Director, Epilepsy Research Center (EpiCenter)
Associate Professor, Department of Anatomy & Neurobiology

A History of Innovation

Join Us in Making an Impact
We are seeking philanthropic partners to establish a home for the Epilepsy Research Center in the Falling Leaves Foundation Medical Innovation Building, and to support our programmatic funding to achieve transformational discoveries.